 |
Twice-Weekly Briefing
Tuesday, October 27, 2026
Issue 261027-75
|
|
|
The MOC Brief
Health policy, priced and translated for self-funded plan sponsors
|
|
In This Edition
Five developments from the past week, and what each one costs you.
| 1. | A Fifth Circuit ruling on October 23 sent website tracking code back to a trial court, and your member-facing pages run the same code. | | 2. | A House committee asked the three largest pharmacy benefit managers for the manuals that set your pharmacy audit terms. | | 3. | Twenty-nine percent of working-age adults in employer plans spend enough of their household income out of pocket to count as underinsured. | | 4. | Prescription drug prices posted the largest drop in a price series that goes back to 1990. | | 5. | Providers put fraud, waste and abuse somewhere between $100 billion and $499 billion, and your TPA reports recoveries without saying what it audited. |
|
|
| 1 · HEALTH DATA PRIVACY · October 23, 2026 |
| A Federal Appeals Court Revived Claims That a Retailer's Website Tracking Code Sent Health Data to Meta |
| The Fifth Circuit ruled on October 23 that five plaintiffs can press claims that Eyemart Express let a Meta tracking pixel on its website carry their health information to Meta without consent. Judges Haynes, Higginson and Ho reversed a dismissal out of the Northern District of Texas in No. 25-10784, and held that "Plaintiffs have Article III standing." Writing for the panel, Judge Higginson said the plaintiffs "have adequately alleged that, by using the Pixel, Eyemart shared Plaintiffs' IIHI with Meta" without their consent, using HIPAA's term for individually identifiable health information, which the panel said "need not reveal a specific diagnosis or condition." The claims run under the federal Wiretap Act, the Missouri Wiretap Act, the Illinois Eavesdropping Act, intrusion upon seclusion and breach of contract, and the court noted that plaintiffs "do not assert a HIPAA claim, nor could they." Nothing was decided on the merits, and the court expressly declined to address whether Eyemart is a HIPAA covered entity. The case returns to the district court to reconsider every substantive claim, and the panel said that if the elements are adequately pled, "discovery will be necessary to test those allegations." |
|
MOC Perspective
Eyemart is an eyewear retailer, not a plan, so nothing here binds you directly. It reaches you because your enrollment portal, your wellness site and your member communication pages run the same analytics and advertising code, and your self-funded plan is itself a HIPAA covered entity, which the court did not have to decide about Eyemart. The cost sits in the vendor contract and the tag manager rather than in clinical data, because the claim here is the transmission itself and not a denied benefit.
What to do now
| ▪ | Pull the full tag list from your benefits portal and member site within 7 days, and count how many of them are advertising or analytics tags rather than functional ones. | | ▪ | Ask your TPA and your benefits administration vendor in writing, with a 30-day response date, whether any tracking code runs on pages behind member login. | | ▪ | Add web tracking language to every business associate agreement covering member-facing pages, and close the gap before your January 1 renewal. |
|
|
| Source: United States Court of Appeals for the Fifth Circuit, No. 25-10784, opinion filed October 23, 2026 |
|
| 2 · PBM OVERSIGHT · October 23, 2026 |
| A House Committee Asked the Three Largest Pharmacy Benefit Managers for Every Provider Manual |
| The chairman of the House Committee on Oversight and Government Reform sent letters on October 23 to CVS Caremark, Express Scripts and Optum Rx asking whether they used pharmacy audits to punish independent pharmacies for backing H.R. 6610, the Pharmacists Fight Back in FEHB Plans Act. The letter to CVS Caremark, addressed to Executive Vice President and President Ed DeVaney, says the committee "is concerned that independent pharmacies have potentially been targeted for punitive audits in retaliation." It asks for a staff briefing "no later than October 30, 2026" and documents "no later than November 6, 2026," covering July 22, 2026 to the present unless the letter says otherwise. The seven requests include "All Provider Manuals," "All pro forma Provider Agreements," every audit type and its auditee selection methodology, the total number of audits of independent pharmacies in each state and territory, and a separate breakdown of audits of Caremark-affiliated against non-affiliated organizations. The committee release describes one audit of a medication costing $0.99 that consumed hundreds of hours of staff time. No audit count has been published, the letters are requests rather than compulsory process, and nothing has been established. |
|
MOC Perspective
The bill at the center of this covers federal employee plans, not yours, and the committee has proved nothing. What matters to you is the paper being asked for. A provider manual and a pro forma provider agreement are the documents that set audit rights, clawback terms and network rules underneath your pharmacy benefit. If a congressional committee has to ask for them, it is worth checking whether your own contract entitles you to them.
What to do now
| ▪ | Request your PBM's current provider manual and pro forma provider agreement in writing, with a 30-day response date. | | ▪ | Read the audit and clawback sections of your pharmacy contract before your January 1 renewal, and note who keeps recovered dollars. | | ▪ | Mark October 30 and November 6 on your renewal calendar, and ask your PBM whether it is producing documents to the committee. |
|
|
| Source: House Committee on Oversight and Government Reform, release and letters of October 23, 2026 |
|
| 3 · MEMBER AFFORDABILITY · October 22, 2026 |
| Twenty-Nine Percent of Working-Age Adults Insured All Year in Employer Plans Were Underinsured |
| The Commonwealth Fund published its 2026 Biennial Health Insurance Survey on October 22 and found that its underinsured measure "includes 29 percent of people with employer-sponsored insurance and half of people in marketplace plans." The survey counts someone insured all year as underinsured if out-of-pocket costs excluding premiums reached 10 percent or more of household income, or 5 percent or more for households below 200 percent of poverty, or if "the individual or family deductible constituted 5 percent or more of household income." Among people in employer plans, "43 percent had avoided care for cost reasons" and 31 percent "were paying off medical bills over time." Across working-age adults insured all year the underinsured share was 30 percent. SSRS fielded the survey from May 7 to July 20, 2026, reaching 9,360 adults, 7,362 of them aged 19 to 64, with a margin of error of plus or minus 1.5 percentage points for that group. Authors Sara R. Collins, Gulcan Cil and Carson Richards write that spending growth "is driven primarily by the provider and pharmaceutical prices that commercial insurers and employers pay." |
|
MOC Perspective
This is a household survey, so it does not separate self-funded plans from fully insured ones, and it measures what happens to your members rather than what you spend. The useful part is the measure itself. Your deductible is a dollar figure in your plan document and a share of household income in your workforce, and only the second one predicts whether people use the coverage they are paying for. A deductible that passes your budget test can still be the reason a member skips care, and 43 percent of working-age adults in employer plans said they avoided care for cost reasons of some kind.
What to do now
| ▪ | Divide your single and family deductibles by the median household income in your lowest-paid job band, and flag any result at 5 percent or more. | | ▪ | Pull your own share of enrolled members with zero claims over 12 months, and read it against the 31 percent still paying off medical bills. | | ▪ | Price a pre-deductible tier for two or three high-value services before your January 1 renewal. |
|
|
| Source: The Commonwealth Fund, 2026 Biennial Health Insurance Survey, published October 22, 2026 |
|
| 4 · PRICE TREND · October 22, 2026 |
| Prescription Drug Prices Fell 4.5 Percent in September, the Largest Drop in a Series That Starts in 1990 |
| Altarum published its October 2026 Health Sector Economic Indicators briefs on October 22 and reported that "prescription drug prices fell by a record 4.5%" in September against a year earlier, "their ninth straight month of lower year-over-year prices." Altarum calls it "the largest decline in drug prices in our time series, which goes back to January 1990." Drug prices had fallen 2.9 percent in August, so the decline is widening rather than fading. The same brief puts price growth for health care services at 2.7 percent for private insurance patients, with "hospital prices for private insurance" up 4.0 percent, while the whole Health Care Price Index sat at 2.1 percent in September, down from 2.3 percent in August. Altarum credits "increased competition from generic drugs and biosimilars" together with the Medicare drug pricing negotiation program. Its companion spending brief puts August prescription drug spending growth at 1.3 percent against 7.8 percent in August 2025, while hospital care spending grew fastest at 8.0 percent. |
|
MOC Perspective
Two of your largest cost lines are now moving in opposite directions, and a single blended trend number will hide it. One caution before you act on the drug figure. Altarum builds its drug component from the consumer price index, which prices what households pay at the counter rather than what your plan pays after rebates, so a record fall in retail drug prices does not become a fall in your net cost per script by itself. That gap is the question to put to your PBM while your hospital line keeps climbing.
What to do now
| ▪ | Split your 2027 renewal projection into a medical trend and a pharmacy trend, and refuse a single blended figure. | | ▪ | Ask your PBM for your net cost per 30-day script across the last nine months, and read the direction against the 4.5 percent decline. | | ▪ | Request your hospital unit cost change by facility for 2026, and test it against the 4.0 percent reported for privately insured patients. |
|
|
| Source: Altarum, Health Sector Economic Indicators price and spending briefs, October 22, 2026 |
|
| 5 · PAYMENT INTEGRITY · October 26, 2026 |
| Fifty-Seven Percent of Providers Put Fraud, Waste and Abuse at About $100 Billion to $499 Billion a Year |
| Aetna released the third-quarter wave of its provider survey on October 26 and reported that 94 percent of providers agreed "fraud, waste and abuse is a problem the health care system needs to address," while "most (57%) estimated that fraud, waste and abuse cost the system about $100B to $499B annually." Morning Consult fielded the survey for Aetna in the third quarter of 2026 among 727 providers, among them hospital executives, physicians, nurses, pharmacists and health information technology leaders, with a margin of error of plus or minus 4 percentage points. Nearly nine in ten providers believe payers can realistically reduce up to half of fraud, waste and abuse each year, and close to 60 percent said lowering overall system costs was the top benefit of doing so. The survey put the average payer-provider trust score at 6.0 on a 1 to 10 scale for the quarter, which Aetna describes as "in line with the 6.1 score reported in Q2" and above the 5.4 recorded in the first quarter. Fewer providers, 67 percent, named administrative burden their top challenge, down seven points from the second quarter. |
|
MOC Perspective
The useful part here is how wide the band is, and that the survey offers nothing narrower. Nobody on either side of a payment integrity audit is working from a firm number. Your TPA reports payment integrity to you as a recovery figure, usually with a fee attached to it, and a recovery figure with no denominator is not a performance measure.
What to do now
| ▪ | Ask your TPA for 12 months of payment integrity recoveries plus the total claims dollars audited to produce them. | | ▪ | Find the fee your vendor keeps on recoveries, stated as a percentage of the dollars returned, and have it in hand before January 1. | | ▪ | Request your 2026 provider appeal reversal rate on payment integrity denials, and compare it against the recoveries you were billed for. |
|
|
| Source: Aetna provider survey, announced by CVS Health, October 26, 2026 |
|
|
The Bottom Line
Four of these five land on paper you already hold: your business associate agreements, your pharmacy contract, the deductible in your plan document, and the recovery figure your TPA reports. None of the four waits on a regulator before you can read it. The exception is the price data in story four, which says national drug prices and hospital prices have stopped moving together, and whether your own two lines have done the same is a question only your PBM and your hospital contracts can answer. Two dates are worth watching: October 30 and November 6, the deadlines the committee asked CVS Caremark to meet for a staff briefing and for documents.
|
|
|
Jude Odu
Founder and Principal, Model Optimal Care
Author of Model Optimal Care: End U.S. Healthcare Waste, One Health Plan at a Time
|
|
|
|